Composition for combination therapy comprising an anti-C-met antibody and a FGFR inhibitor

摘要

Provided is a composition for use in combination therapy for prevention or treatment of a cancer including a FGFR inhibitor and an anti-c-Met antibody or an antigen-binding fragment thereof as active ingredients. The composition for use in combination therapy can achieve an excellent synergistic effect and lower the effective dose of the anti-c-Met antibody, thereby enabling a more effective cancer treatment.